PMV Pharma director granted 42,000 stock options
PMV Pharmaceuticals director Kirsten Flowers received a stock option grant covering 42,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PMV Pharmaceuticals director Kirsten Flowers received a stock option grant covering 42,000 shares of common stock. The options have an exercise price of $1.19 per share and expire on June 4, 2036. These options vest on the earlier of June 4, 2027 or the date of the company’s next annual stockholder meeting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 42,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders.
Key Figures
Key Terms
Stock Option (right to buy) financial
exercise price financial
expiration date financial
vest financial
annual meeting of stockholders financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PMVP director Kirsten Flowers report in this Form 4?
What is the exercise price of the PMVP stock options granted to Kirsten Flowers?
When do Kirsten Flowers’ PMVP stock options vest?
When do the PMVP stock options granted to Kirsten Flowers expire?
How many PMVP options does Kirsten Flowers hold after this grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.